Emergex goes for gold, raises $11M for dengue vaccine Jan. 9, 2020 By Nuala Moran LONDON – Emergex Vaccines Holdings Ltd. has raised $11 million in a series A to fund phase I development of the lead product against dengue fever.Read More
